Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-14T18:50:26.717Z Has data issue: false hasContentIssue false

Chapter 25 - Management of Acute Hematological Malignancy in Pregnancy

from Section 9 - Malignant Conditions

Published online by Cambridge University Press:  01 February 2018

By
Sahra Ali  and
Gill Swallow
Edited by
Sue Pavord  and
Beverley Hunt
Sue Pavord
Affiliation:
University of Oxford
Beverley Hunt
Affiliation:
King's College London
Get access
Type
Chapter
Information
The Obstetric Hematology Manual , pp. 309 - 319
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Swerdlow, SH, Campo, E, Pileri, SA. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375–2390.Google Scholar
Cancer Research UK. Cancer Research UK Hodgkin Lymphoma Incidence Statistics; 2011. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/hodgkinslymphoma/incidence/uk-hodgkins-lymphoma-incidence-statistics (accessed May 28 2015).Google Scholar
Pereg, D, Koren, G, Lishner, M. The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy. Hematologica 2007; 92: 1230–1237.CrossRefGoogle ScholarPubMed
Bachanova, V, Connors, JM. Hodgkin lymphoma in pregnancy. Current Hematologic Malignancy Reports 2013; 8: 211–217.Google Scholar
Rizack, T, Mega, A, Legare, R, Castillo, J. Management of hematological malignancies during pregnancy. American Journal of Hematology 2009; 84: 830–841.Google Scholar
Evens, A, Advani, R, Press, OW et al. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. Journal of Clinical Oncology 2013; 32: 4132–4139.Google Scholar
Follows, GA, Ardeshna, KM, Barrington, SF et al.; on behalf of the British Committee for Standards in Hematology. Guidelines for the first line management of classical Hodgkin lymphoma. British Journal of Haematology 2014; 166: 34–49.CrossRefGoogle ScholarPubMed
Horowitz, NA, Benyamini, N, Wohlfart, K, Brenner, B, Avivi, I. Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review. Lancet Oncology 2013; 14: 275–282.Google Scholar
Eyre, TA, Lau, IJ, Mackillop, L, Collins, GP. Management and controversies of classical Hodgkin lymphoma in pregnancy. British Journal of Haematology 2015; 169: 613–630CrossRefGoogle ScholarPubMed
Avilés, A, Natividad, N, Marıa-Jesus, N. Hematological malignancies and pregnancy: Treat or no treat during first trimester? International Journal of Cancer 2012; 131: 2678–2683.Google Scholar
Avivi, I, Connors, JM, Brenner, B, Horowitz, NA. Non-Hodgkin lymphomas in pregnancy: Tackling therapeutic quandaries. Blood Reviews 2014; 28: 213–220.Google Scholar
Guven, S, Ozcebe, OI, Tuncer, ZS. Non-Hodgkin’s lymphoma complicating pregnancy: A case report. European Journal of Gynaecological Oncology 2005; 26: 457–458.Google ScholarPubMed
Decker, M, Rothermundt, C, Hollander, G, et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncology 2006; 7: 693–694.Google Scholar
Rey, J, Coso, D, Roger, V et al. Rituximab combined with chemotherapy for lymphoma during pregnancy. Leukemia Research 2009; 33: 8–9.Google Scholar
Chakravarty, EF, Murray, ER, Kelman, A, Farmer, P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011; 117 (5): 1499–1506.Google Scholar
Antid, N, Colovid, M, Cemerikid, V et al. Disseminated Burkitt like lymphoma during pregnancy. Medical Oncology 2000; 17; 233–236.Google Scholar
Magloire, LK, Pattker, CM, Buhimschi, CS, Funai, EF. Burkitt’s lymphoma of the ovary in pregnancy. American Journal of Obstetrics and Gynecology 2006; 108(3): 743–745.Google ScholarPubMed
Petersen, C, Lester, DR, Sanger, W. Burkitts lymphoma in early pregnancy. Journal of Clinical Oncology 2010; 28 (9): 136–138.Google Scholar
Amant, F, Van Calsteren, K, Halaska, MJ. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: An observational study. Lancet Oncology 2012; 13: 256–264.Google Scholar
Amant, F, Han, SN, Gziri, MM, Dekrem, J, Van Calsteren, K. Chemotherapy during pregnancy. Current Opinion in Oncology 2012; 24(5): 580–586.CrossRefGoogle ScholarPubMed
Hurley, TJ, McKinnel, JV, Irani, MS. Hematologic malignancies in pregnancy. Obstetric and Gynecology Clinics of North America 2005; 32: 595–614.Google Scholar
Gziri, MM. Effects of chemotherapy during pregnancy on the maternal and fetal heart. Prenatal Diagnosis 2012; 32(7): 614–619.Google Scholar
Greenlund, LJ, Letendre, L, Tefferi, A. Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leukemia and Lymphoma 2001; 41: 571–577.Google Scholar
Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncology 2004; 5: 283–291.Google Scholar
Reynoso, EE, Shepherd, FA, Messner, HA et al. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. Journal of Clinical Oncology 1987; 5: 1098–1106.Google Scholar
Cheghoum, Y, Vey, N, Raffoux, E et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 2005; 104: 110–117.Google Scholar
Meyer-Wittkopf, M, Barth, H, Emons, G, Schmidt, S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound in Obstetrics and Gynecology 2001; 18: 62–66.CrossRefGoogle ScholarPubMed
Shapira, T, Pereg, D, Lishner, M. How I treat acute and chronic leukemia in pregnancy. Blood Reviews 2008; 22: 247–259.Google Scholar
Wagner, VM, Hill, JS, Weaver, D, Behner, RL. Congenital abnormalities in baby born to cytarabine treated mother. Lancet 1980; 316: 98–99.Google Scholar
Artlich, A, Möller, J, Kruse, K et al. Teratogenic effects in a case of maternal treatment for acute myelocytic leukemia – neonatal and infantile course. European Journal of Pediatrics 1994; 153: 488–491.Google Scholar
Schafer, AI. Teratogenic effects of antileukemic chemotherapy. Archives of Internal Medicine 1981; 141: 514–515.CrossRefGoogle ScholarPubMed
Avilés, A, Niz, J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Medical and Pediatric Oncology 1988; 16: 3–6.CrossRefGoogle ScholarPubMed
Cantini, E, Yanes, B. Acute myelogenous leukemia in pregnancy. Southern Medical Journal 1984; 77: 1050–1052.Google Scholar
Breccia, M, Mengarelli, A, Mancini, M et al. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Leukemia Research 2005; 29: 749–754.CrossRefGoogle Scholar
Ikeda, Y, Masuzaki, H, Nakayama, D et al. Successful management and perinatal outcome of pregnancy complicated with myelodysplastic syndrome. Leukemia Research 2002; 26: 255–260.Google Scholar
Siddiqui, T, Elfenbein, GJ, Noyes, WD et al. Myelodysplastic syndromes presenting in pregnancy. A report of five cases and the clinical outcome. Cancer 1990; 66: 377–381.Google Scholar
Pagliuca, A, Mufti, GJ, Fenaux, P et al. Myelodysplastic syndromes during pregnancy. European Journal of Hematology 1991; 47: 310–312.Google Scholar
Fadilah, SA, Roswati, MN. Refractory anemia with excess of blasts in transformation (RAEB-T) during pregnancy with hematological remission following delivery. British Journal of Haematology 1999; 104: 935–936.CrossRefGoogle ScholarPubMed
Essien, EM, Sharma, U, Upadhaya, K, Malik, R. Myelodysplastic syndrome and successful pregnancy. International Journal of Hematology 1998; 68: 449–452.CrossRefGoogle ScholarPubMed
Yang, Z, Mei-Ying, L, Shan-Mi, W, Xiao-Hui, Z. Pregnancy and myelodysplastic syndrome: an analysis of the clinical characteristics, maternal and fetal outcomes. Journal of Maternal and Fetal Neonatal Medicine 2015; 28(18): 2155–2159.CrossRefGoogle Scholar
Hellstrom-Lindberg, E. Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. British Journal of Haematology 1995; 89: 67–71.CrossRefGoogle ScholarPubMed
Royal College of Obstetricians and Gynecologists. Bacterial Sepsis following Pregnancy. Green-Top Clinical Guideline No. 64b. London: Royal College of Obstetricians and Gynecologists; 2012. http://www.rcog.org.uk/files/rcog-corp/11.6.12GTG64b.pdf (accessed June 1 2014).Google Scholar
Einarson, A, Maltepe, C, Navioz, Y et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. British Journal of Obstetrics and Gynecology 2004; 111: 940–943.Google Scholar
Lynch, CM, Herold, AH. Use of antibiotics during pregnancy. Medical News and Events, 1991. http://www.drplace.com/Use_of_antibiotics_during_pregnancy.16.18138.htm (accessed July 11 2017).Google Scholar
King, CT, Rogers, PD, Cleary, JD Chapman, SW. Antifungal therapy during pregnancy. Clinical Infectious Diseases 1998; 27: 1151–1160.Google Scholar
The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) position statement. Provision of cytomegalovirus tested blood components position statement; 2012. https://www.gov.uk/government/news/provision-of-cytomegalovirus-tested-blood-components-position-statement-published (accessed July 11 2017).Google Scholar
Royal College of Obstetricians and Gynecologists. Green-Top Clinical Guideline No. 7 Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality. London: Royal College of Obstetricians and Gynecologists; 2010. http://www.rcog.org.uk/files/rcog-corp/GTG%207.pdf (accessed June 1 2014).Google Scholar
RCOG. Magnesium Sulphate to Prevent Cerebral Palsy following Preterm Birth. RCOG Scientific Impact Paper No.29. 2011. https://www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_29.pdf (accessed June 1 2014).Google Scholar
Qureshi, H, Masse, E, Kirwan, D et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of hemolytic disease of the fetus and newborn. Transfusion Medicine 2014; 24: 8–20.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×